Literature DB >> 22190480

Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.

Yesenia Santiago-Casas1, Luis M Vilá, Gerald McGwin, Ryan S Cantor, Michelle Petri, Rosalind Ramsey-Goldman, John D Reveille, Robert P Kimberly, Graciela S Alarcón, Elizabeth E Brown.   

Abstract

OBJECTIVE: To determine the clinical manifestations and disease damage associated with discoid rash in a large multiethnic systemic lupus erythematosus (SLE) cohort.
METHODS: SLE patients (per American College of Rheumatology [ACR] criteria) ages ≥16 years with a disease duration of ≤10 years at enrollment and defined ethnicity (African American, Hispanic, or white) from a longitudinal cohort were studied. Socioeconomic-demographic features, clinical manifestations, and disease damage (per the Systemic Lupus International Collaborating Clinics/ACR Damage Index) were determined. The association of discoid lupus erythematosus (DLE) with clinical manifestations and disease damage was examined using multivariable logistic regression.
RESULTS: A total of 2,228 SLE patients were studied. The mean ± SD age at diagnosis was 34.3 ± 12.8 years and the mean ± SD disease duration was 7.9 ± 6.0 years; 91.8% were women. DLE was observed in 393 patients with SLE (17.6%). In the multivariable analysis, patients with DLE were more likely to be smokers and of African American ethnicity and to have malar rash, photosensitivity, oral ulcers, leukopenia, and vasculitis. DLE patients were less likely to be of Hispanic (from Texas) ethnicity and to have arthritis, end-stage renal disease, and antinuclear, anti-double-stranded DNA, and antiphospholipid antibodies. Patients with DLE had more damage accrual, particularly chronic seizures, scarring alopecia, scarring of the skin, and skin ulcers.
CONCLUSION: In this cohort of SLE patients, DLE was associated with several clinical features, including serious manifestations such as vasculitis and chronic seizures.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 22190480      PMCID: PMC3559016          DOI: 10.1002/acr.21581

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  50 in total

Review 1.  Molecular genetics of cutaneous lupus erythematosus.

Authors:  T P Millard; J M McGregor
Journal:  Clin Exp Dermatol       Date:  2001-03       Impact factor: 3.470

2.  Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.

Authors:  M L Jewell; D P McCauliffe
Journal:  J Am Acad Dermatol       Date:  2000-06       Impact factor: 11.527

3.  Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study.

Authors:  Shyamal Wahie; Ann K Daly; Heather J Cordell; Mark J Goodfield; Stephen K Jones; Christopher R Lovell; Andrew J Carmichael; Mary M Carr; Angela Drummond; Sivakumar Natarajan; Catherine H Smith; Nick J Reynolds; Simon J Meggitt
Journal:  J Invest Dermatol       Date:  2011-07-07       Impact factor: 8.551

4.  The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.

Authors:  D D Gladman; C H Goldsmith; M B Urowitz; P Bacon; P Fortin; E Ginzler; C Gordon; J G Hanly; D A Isenberg; M Petri; O Nived; M Snaith; G Sturfelt
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

5.  Epidemiology of cutaneous lupus erythematosus in a tertiary referral centre in Singapore.

Authors:  P P Ng; S H Tan; E T Koh; T Tan
Journal:  Australas J Dermatol       Date:  2000-11       Impact factor: 2.875

6.  Skin lesions--an indicator of disease activity in systemic lupus erythematosus?

Authors:  R D Zecević; D Vojvodić; B Ristić; M D Pavlović; D Stefanović; D Karadaglić
Journal:  Lupus       Date:  2001       Impact factor: 2.911

7.  Baseline characteristics of a multiethnic lupus cohort: PROFILE.

Authors:  G S Alarcón; G McGwin; M Petri; J D Reveille; R Ramsey-Goldman; R P Kimberly
Journal:  Lupus       Date:  2002       Impact factor: 2.911

8.  Risk factors for central nervous system involvement in systemic lupus erythematosus.

Authors:  F B Karassa; J P Ioannidis; G Touloumi; K A Boki; H M Moutsopoulos
Journal:  QJM       Date:  2000-03

9.  Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort.

Authors:  Y Molad; A Gorshtein; A J Wysenbeek; D Guedj; R Majadla; A Weinberger; M Amit-Vazina
Journal:  Lupus       Date:  2002       Impact factor: 2.911

Review 10.  Cutaneous lupus erythematosus: diagnosis and management.

Authors:  Paolo Fabbri; Carla Cardinali; Barbara Giomi; Marzia Caproni
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

View more
  12 in total

1.  Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus.

Authors:  Joseph F Merola; Stephen D Prystowsky; Christina Iversen; Jose A Gomez-Puerta; Tabatha Norton; Peter Tsao; Elena Massarotti; Peter Schur; Bonnie Bermas; Karen H Costenbader
Journal:  J Am Acad Dermatol       Date:  2013-03-28       Impact factor: 11.527

2.  Late-onset systemic lupus erythematosus associated with inverse discoid lupus erythematosus on the buttock.

Authors:  Brenna G Kelly; Brayden R Forbes; Rebecca M Thiede
Journal:  JAAD Case Rep       Date:  2022-04-26

3.  Natural history of disease activity and damage in patients with cutaneous lupus erythematosus.

Authors:  Khor Jia Ker; Noelle M Teske; Rui Feng; Benjamin F Chong; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2018-06-30       Impact factor: 11.527

4.  Pediatric systemic lupus erythematosus. Retrospective analysis of clinico-laboratory parameters and their association with Systemic Lupus Erythematosus Disease Activity Index score.

Authors:  Siti Khadijah S M Nazri; Kah K Wong; Wan Zuraida W A Hamid
Journal:  Saudi Med J       Date:  2018-06       Impact factor: 1.484

Review 5.  Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.

Authors:  Kristen L Chen; Rebecca L Krain; Victoria P Werth
Journal:  F1000Res       Date:  2019-03-25

6.  Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus.

Authors:  Yirong Xiang; Mengtao Li; Hui Luo; Yanhong Wang; Xinwang Duan; Cheng Zhao; Feng Zhan; Zhenbiao Wu; Hongbin Li; Min Yang; Jian Xu; Wei Wei; Lijun Wu; Hanxiao You; Junyan Qian; Xiaoxi Yang; Can Huang; Jiuliang Zhao; Qian Wang; Xiaomei Leng; Xinping Tian; Yan Zhao; Xiaofeng Zeng
Journal:  Arthritis Res Ther       Date:  2021-01-11       Impact factor: 5.156

Review 7.  Rheumatic diseases in Africa.

Authors:  Olufemi Adelowo; Girish M Mody; Mohammed Tikly; Omondi Oyoo; Samy Slimani
Journal:  Nat Rev Rheumatol       Date:  2021-04-13       Impact factor: 20.543

8.  Lupus nephritis correlates with B cell interferon-β, anti-Smith, and anti-DNA: a retrospective study.

Authors:  Fatima Alduraibi; Huma Fatima; Jennie A Hamilton; W Winn Chatham; Hui-Chen Hsu; John D Mountz
Journal:  Arthritis Res Ther       Date:  2022-04-18       Impact factor: 5.606

Review 9.  Unmet medical needs in systemic lupus erythematosus.

Authors:  Aisha Lateef; Michelle Petri
Journal:  Arthritis Res Ther       Date:  2012-12-18       Impact factor: 5.156

10.  Coexistence of ankylosing spondylitis and discoid lupus: A case report.

Authors:  Ayse Unal Enginar; Hakan Nur; Cahit Kacar
Journal:  North Clin Istanb       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.